Cargando…
The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study
(1) Background: Although Non-Invasive Ventilation (NIV) is effective in preventing mortality and endotracheal intubation in patients with Acute Respiratory Failure (ARF) linked to a neuromuscular disorder, its efficacy can be affected by patient intolerance. A High-Flow Nasal Cannula (HFNC) appears...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531616/ https://www.ncbi.nlm.nih.gov/pubmed/37763001 http://dx.doi.org/10.3390/jcm12186061 |
_version_ | 1785111761067704320 |
---|---|
author | Lionello, Federico Lapia, Francesco Molena, Beatrice Padoan, Andrea Lococo, Sara Arcaro, Giovanna Guarnieri, Gabriella Vianello, Andrea |
author_facet | Lionello, Federico Lapia, Francesco Molena, Beatrice Padoan, Andrea Lococo, Sara Arcaro, Giovanna Guarnieri, Gabriella Vianello, Andrea |
author_sort | Lionello, Federico |
collection | PubMed |
description | (1) Background: Although Non-Invasive Ventilation (NIV) is effective in preventing mortality and endotracheal intubation in patients with Acute Respiratory Failure (ARF) linked to a neuromuscular disorder, its efficacy can be affected by patient intolerance. A High-Flow Nasal Cannula (HFNC) appears to have a significant advantage over NIV as far as patient tolerance is concerned. The aim of the study was to investigate HFNC’s safety profile in a group of consecutive Neuromuscular Disease (NMD) patients intolerant to NIV who were admitted to an Intermediate Respiratory Care Unit (IRCU) for ARF. (2) Methods: The clinical course of nine NMD patients intolerant to NIV and switched to HFNC was reported. HFNC was provided during daytime hours and NIV during the night-time to the NIV-intolerant patients. HFNC was utilized 24 h a day in those patients who were intolerant of even nocturnal NIV. (3) Results: HFNC was simple to use and it was well tolerated by all of the patients. Three out of nine patients experienced treatment failure, consisting of the need for ETI and/or death during their IRCU stay. The remaining 6 had a favorable outcome. Treatment failure was linked to the utilization of HFNC 24 h a day. (4) Conclusion: HFNC during the daytime hours, together with nocturnal NIV, seems to be a safe therapeutic approach for NMD patients with ARF. A round-the-clock use of HFNC tends to be linked to a high likelihood of failure. |
format | Online Article Text |
id | pubmed-10531616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105316162023-09-28 The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study Lionello, Federico Lapia, Francesco Molena, Beatrice Padoan, Andrea Lococo, Sara Arcaro, Giovanna Guarnieri, Gabriella Vianello, Andrea J Clin Med Brief Report (1) Background: Although Non-Invasive Ventilation (NIV) is effective in preventing mortality and endotracheal intubation in patients with Acute Respiratory Failure (ARF) linked to a neuromuscular disorder, its efficacy can be affected by patient intolerance. A High-Flow Nasal Cannula (HFNC) appears to have a significant advantage over NIV as far as patient tolerance is concerned. The aim of the study was to investigate HFNC’s safety profile in a group of consecutive Neuromuscular Disease (NMD) patients intolerant to NIV who were admitted to an Intermediate Respiratory Care Unit (IRCU) for ARF. (2) Methods: The clinical course of nine NMD patients intolerant to NIV and switched to HFNC was reported. HFNC was provided during daytime hours and NIV during the night-time to the NIV-intolerant patients. HFNC was utilized 24 h a day in those patients who were intolerant of even nocturnal NIV. (3) Results: HFNC was simple to use and it was well tolerated by all of the patients. Three out of nine patients experienced treatment failure, consisting of the need for ETI and/or death during their IRCU stay. The remaining 6 had a favorable outcome. Treatment failure was linked to the utilization of HFNC 24 h a day. (4) Conclusion: HFNC during the daytime hours, together with nocturnal NIV, seems to be a safe therapeutic approach for NMD patients with ARF. A round-the-clock use of HFNC tends to be linked to a high likelihood of failure. MDPI 2023-09-19 /pmc/articles/PMC10531616/ /pubmed/37763001 http://dx.doi.org/10.3390/jcm12186061 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Lionello, Federico Lapia, Francesco Molena, Beatrice Padoan, Andrea Lococo, Sara Arcaro, Giovanna Guarnieri, Gabriella Vianello, Andrea The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study |
title | The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study |
title_full | The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study |
title_fullStr | The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study |
title_full_unstemmed | The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study |
title_short | The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study |
title_sort | safety of a high-flow nasal cannula in neuromuscular disease patients with acute respiratory failure: a retrospective case-series study |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531616/ https://www.ncbi.nlm.nih.gov/pubmed/37763001 http://dx.doi.org/10.3390/jcm12186061 |
work_keys_str_mv | AT lionellofederico thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT lapiafrancesco thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT molenabeatrice thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT padoanandrea thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT lococosara thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT arcarogiovanna thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT guarnierigabriella thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT vianelloandrea thesafetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT lionellofederico safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT lapiafrancesco safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT molenabeatrice safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT padoanandrea safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT lococosara safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT arcarogiovanna safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT guarnierigabriella safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy AT vianelloandrea safetyofahighflownasalcannulainneuromusculardiseasepatientswithacuterespiratoryfailurearetrospectivecaseseriesstudy |